NEW YORK, July 12, 2013 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors of Amyris, Inc.("Amyris" or the "Company") (Nasdaq:AMRS) of the Monday, July 15, 2013 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and the President and Chief Executive Officer.
A complaint has been filed on behalf of all persons who purchased or otherwise acquired Amyris securities between April 29, 2011 and February 8, 2012 (the "Class Period").
The action alleges that the Company and the President and Chief Executive Officer violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies. Specifically, the action focuses on whether Amyris made false and misleading statements to the investing public regarding its ability to produce Biofene, a renewable chemical.
On February 9, 2012, the Company disclosed that there would be a decrease in Biofene production and that it needed to raise funds. Following this news, Amyris' stock dropped $2.74, or over 28%.
Request more information now by clicking here: www.faruqilaw.com/AMRS. There is no cost or obligation to you.
If you invested in Amyris stock or options between April 29, 2011 and February 8, 2012 and would like to discuss your legal rights, visit www.faruqilaw.com/AMRS. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Amyris' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CONTACT: FARUQI & FARUQI, LLP 369 Lexington Avenue, 10th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. email@example.com Francis McConville, Esq. firstname.lastname@example.org Telephone: (877) 247-4292 or (212) 983-9330